Regulation effect of Aspirin Eugenol Ester on blood lipids in Wistar rats with hyperlipidemia

BMC Veterinary Research

Table 2 Body weights changes of rats before and after drug treatment

Groups	Body weight (g)
Groups	Before drug treatment	Fifth week after drug treatment
A	276.1 ± 6.4^aa	330.1 ± 5.6^bb
B	295.4 ± 7.1	358.8 ± 7.2
C	298.4 ± 5.6	347.3 ± 6.8^b
D	303.6 ± 7.3	340.8 ± 5.9^bb
E	299.5 ± 6.9	340.8 ± 8.1 ^bb
F	301.1 ± 5.9	339.3 ± 6.4 ^bb
G	305.6 ± 6.9	343.4 ± 5.1 ^bb
H	292.6 ± 5.3	321.1 ± 5.9 ^bb
I	306.8 ± 5.9	342.4 ± 7.1 ^bb
J	302.7 ± 6.7	352.3 ± 6.6

Note: A: blank group, B: model group, C: AEE low dose, D: AEE medium dose, E: AEE high dose, F: integration group (acetylsalicylic acid: eugenol, molar ratio 1:1, 0.11 mmol), G: acetylsalicylic acid group, H: eugenol group, I: simvastatin group, J: CMC-Na group. ^aa P < 0.01 significant difference from model group before administration. ^b P < 0.05, ^bb P < 0.01 significant difference from model group after administration. The time before drug treatment was the end of 8th week after HFD diet was used and fifth week after drug treatment was the end of 13th week after HFD diet was used

ISSN: 1746-6148